Model Lists News Today

This research letter highlights opportunities for researchers to develop more innovative treatments for skin disease, especially for conditions that have unmet therapeutic needs.

The World Health Organisation has added over 500 lifesaving essential medicines to its essential list including the first approvals for multiple sclerosis.

The World Health Organization (WHO) has updated its guidelines for essential medicines to include cancer, infectious disease, heart conditions, cardiovascular, and more..

Clinical trial evidence showing the use of polypills associated with reduced risks of cardiovascular events has been made to the list of essential medicines.

The World Health Organization updated its guidelines for essential medicines Wednesday to include drugs to treat multiple sclerosis, heart conditions, cancer and more. But obesity medications were not added to the list, despite requests this year from researchers in the United States.

The World Health Organization has published the new editions of the Model Lists of Essential Medicines (EML) and Essential Medicines for Children (EMLc). The latest update includes important new medicines for the treatment of multiple sclerosis, cancer, infectious diseases, and cardiovascular conditions, among others.

The World Health Organization (WHO) has published the Model Lists of Essential Medicines (EML) which could have a very large public health impact globally without jeopardising the health budgets of low- and middle-income countries.

The World Health Organization (WHO) has updated the Model Lists of Essential Medicines (EML) and Essential Medicines for Children (EMLc), by adding many innovative medicines. TheHealthSite.com

The World Health Organization updated its guidelines for essential medicines Wednesday to include drugs to treat multiple sclerosis, heart conditions, cancer and more. But obesity medications were not added to the list, despite requests this year from researchers in the United States.

MPP signs licence agreement to increase access to nilotinib for the treatment of chronic myeloid leukaemia20 October 2022This is the first ever public health-oriented voluntary licence agreementon a cancer medicineGeneva – On the side lines of the World Cancer Congress, the Medicines Patent Pool (MPP) tod...